Safety and Pharmacokinetic Profile of BTA585, a Novel Fusion Inhibitor of Respiratory Syncytial Virus, in Single and Multiple-Ascending Dose Healthy Volunteer Studies | Zendy

AI Assistant Blog Pricing

Safety and Pharmacokinetic Profile of BTA585, a Novel Fusion Inhibitor of Respiratory Syncytial Virus, in Single and Multiple-Ascending Dose Healthy Volunteer Studies

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.